In a double-blind , randomized , placebo-controlled trial , we investigated the effect of long-acting vitamin D3 ( 400,000 IU ) on sputum neutrophils and eosinophils in 44 patients with nonatopic asthma with neutrophilic ( 53 % ) and/or eosinophilic ( 3 % ) airway inflammation .